西门塔尔牛胰腺间充质干细胞原代培养及其多向分化潜能研究

doi:10.11843/j.issn.0366-6964.2022.11.007

摘要/Abstract

摘要： 旨在对西门塔尔牛胰腺间充质干细胞（pancreatic mesenchymal stem cells，PMSCs）进行原代培养并研究其体外分化潜能，为细胞疗法和组织工程学方面提供新的种子细胞。本研究从3月龄的西门塔尔牛胚胎中无菌分离胰腺组织，分别采用胶原酶消化法和组织块贴壁法分离PMSCs，进行原代培养；绘制第3代、第9代、第15代细胞生长曲线并测定群体倍增时间及克隆形成能力，采用免疫荧光检测干细胞表面标志物（CD29、CD44、CD73、CD90、CD34和CD45），RT-PCR检测干细胞细胞表面标志物（CD29、CD44、CD73、CD90、CD106、CD166、CD34和CD45）；染色体核型分析检测其基因稳定性，通过向成脂、成骨、成软骨和成肝样细胞诱导分化，检测其多向分化潜能。结果表明，两种方法都可成功分离出PMSCs，细胞贴壁后形态均为长梭形，漩涡状生长，生长趋势呈典型的S形；第9代细胞群体倍增时间显著低于第15代而高于第3代（P<0.01）；第9代PMSCs克隆形成率显著低于第3代而显著高于第15代（P<0.05）；免疫荧光结果表明，PMSCs特异性表达CD29、CD44、CD73和CD90，RT-PCR结果显示PMSCs特异性表达CD29、CD44、CD73、CD90、CD106和CD166，未表达造血细胞表面标志物CD34和CD45，与国际细胞治疗学会组织干细胞委员会指定的MSCs表面标记物相对应；核型分析表明，PMSCs为正常二倍体（2n=60，XY），染色体基因组未发生变异；特异性染色和RT-PCR结果表明，从西门塔尔牛体内获得的PMSCs可分化为脂肪细胞、骨细胞、软骨细胞和肝样细胞。本试验证实两种方法均可成功建立西门塔尔牛PMSCs体外分离培养体系，PMSCs具有活性好、增殖速度快的特点，与MSCs有相似的生物学特性和多项分化的潜能。可为组织工程学提供新的种子细胞。

关键词: 胰腺间充质干细胞, 西门塔尔牛, 原代培养, 生物学特征, 分化潜能

Abstract: The purpose of the experiment was to primary culture and study the in vitro differentiation potential of Simmental bovine pancreatic mesenchymal stem cells (PMSCs), and to provide new seed cells for cell therapy and tissue engineering. Pancreatic tissue was aseptically isolated from 3-month-old Simmental cattle embryos, and PMSCs were isolated by collagenase digestion and tissue block adherence, respectively, and then primary cultured. The growth curves of 3rd, 9th and 15th passage cells were drawn and the population doubling time and clone formation ability were determined. Stem cell surface markers (CD29, CD44, CD73, CD90, CD34 and CD45) were detected by immunofluorescence, and stem cell surface markers (CD29, CD44, CD73, CD90, CD106, CD166, CD34 and CD45) were detected by RT-PCR. Its gene stability was detected by karyotype analysis, the multi-directional differentiation potential was detected by inducing adipogenic, osteogenic, chondrogenic and hepatocyte-like cells. The results showed that PMSCs could be successfully isolated by both methods. After the cells adhered, they were all long spindle-shaped, swirling growth, and the growth trend was typical S-shaped. The doubling time of the cell population in the 9th passage was significantly lower than that in the 15th passage and higher than that in the 3rd passage (P<0.05); The clone formation rate of the 9th passage of PMSCs was significantly lower than that of the 3rd passage and significantly higher than that of the 15th passage (P<0.05); Immunofluorescence results showed that CD29, CD44, CD73 and CD90 specifically expressed in PMSCs, and RT-PCR results showed that CD29, CD44, CD73, CD90, CD106 and CD166 specifically expressed in PMSCs, but the hematopoietic cell surface markers CD34 and CD45 did not express, which were consistent with international corresponding to the surface markers of MSCs designated by the Tissue Stem Cell Committee of the Society for Cell Therapy; Karyotype analysis showed that PMSCs were normal diploid (2n=60, XY), and there was no mutation in the chromosomal genome; Specific staining and RT-PCR results showed that PMSCs obtained from Simmental cattle could differentiate into adipocytes, osteocytes, chondrocytes and hepatocyte-like cells. This experiment confirmed that both methods could successfully establish the in vitro separation and culture system of Simmental cattle PMSCs. PMSCs showed good proliferation activity, similar biological properties and multiple differentiation potentials with MSCs. The results could provide new seed cells for tissue engineering.

Key words: pancreatic mesenchymal stem cells, Simmental cattle, primary culture, biological characteristics, differentiation potential

中图分类号:

S823.1

王育南, 吴月, 宋哈楠, 张涛, 关伟军. 西门塔尔牛胰腺间充质干细胞原代培养及其多向分化潜能研究[J]. 畜牧兽医学报, 2022, 53(11): 3786-3796.

WANG Yunan, WU Yue, SONG Hanan, ZHANG Tao, GUAN Weijun. Primary Culture of Simmental Bovine Pancreatic Mesenchymal Stem Cells and Their Multi-directional Differentiation Potential[J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(11): 3786-3796.

参考文献 34

[1]	The prevention of diabetes mellitus[J].JAMA, 2021, 325(2):190.
[2]	ZHOU Q, MELTON D A.Pancreas regeneration[J].Nature, 2018, 557(7705):351-358.
[3]	PAN F C, BRISSOVA M.Pancreas development in humans[J].Curr Opin Endocrinol Diabetes Obes, 2014, 21(2):77-82.
[4]	BAKHTI M, BÖTTCHER A, LICKERT H.Modelling the endocrine pancreas in health and disease[J].Nat Rev Endocrinol, 2019, 15(3):155-171.
[5]	RYAN E A, PATY B W, SENIOR P A, et al.Five-year follow-up after clinical islet transplantation[J].Diabetes, 2005, 54(7):2060-2069.
[6]	SOLIS M A, VELÁSQUEZ I M, CORREA R, et al.Stem cells as a potential therapy for diabetes mellitus:a call-to-action in Latin America[J].Diabetol Metab Syndr, 2019, 11:20.
[7]	BHARTIYA D.Stem cells to replace or regenerate the diabetic pancreas:huge potential & existing hurdles[J].Indian J Med Res, 2016, 143(3):267-274.
[8]	CHEN B, ZHOU L, WANG L S, et al.Better induction and differentiation strategy for rat pancreatic stem cells:transplant in liver niche[J].Transplant Proc, 2009, 41(9):3898-3904.
[9]	SCHARFMANN R, XIAO X W, HEIMBERG H, et al.Beta cells within single human islets originate from multiple progenitors[J].PLoS One, 2008, 3(10):e3559.
[10]	ZHANG S, YIN J H, JI H B, et al.Functional β-cell differentiation of small-tail Han sheep pancreatic mesenchymal stem cells and the therapeutic potential in type 1 diabetic mice[J].Pancreas, 2020, 49(7):947-954.
[11]	SEEBERGER K L, DUFOUR J M, SHAPIRO A M J, et al.Expansion of mesenchymal stem cells from human pancreatic ductal epithelium[J].Lab Invest, 2006, 86(2):141-153.
[12]	GOPURAPPILLY R, BHAT V, BHONDE R.Pancreatic tissue resident mesenchymal stromal cell (MSC)-like cells as a source of in vitro islet neogenesis[J].J Cell Biochem, 2013, 114(10):2240-2247.
[13]	COOPER T T, SHERMAN S E, BELL G I, et al.Characterization of a Vimentinhigh/Nestinhigh proteome and tissue regenerative secretome generated by human pancreas-derived mesenchymal stromal cells[J].Stem Cells, 2020, 38(5):666-682.
[14]	PIXLEY J S.Mesenchymal stem cells to treat type 1 diabetes[J].Biochim Biophys Acta Mol Basis Dis, 2020, 1866(4):165315.
[15]	THAKKAR U G, TRIVEDI H L, VANIKAR A V, et al.Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus[J].Cytotherapy, 2015, 17(7):940-947.
[16]	PÄTH G, PERAKAKIS N, MANTZOROS C S, et al.Stem cells in the treatment of diabetes mellitus-Focus on mesenchymal stem cells[J].Metabolism, 2019, 90:1-15.
[17]	KHIATAH B, QI M, DU W T, et al.Intra-pancreatic tissue-derived mesenchymal stromal cells:a promising therapeutic potential with anti-inflammatory and pro-angiogenic profiles[J].Stem Cell Res Ther, 2019, 10(1):322.
[18]	THIRLWELL K L, COLLIGAN D, MOUNTFORD J C, et al.Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions[J].Cytotherapy, 2020, 22(12):762-771.
[19]	LIU Y L, LI F P, CAI Z G, et al.Isolation and characterization of mesenchymal stem cells from umbilical cord of giant panda[J].Tissue Cell, 2021, 71:101518.
[20]	LUO H N, LI D S, CHEN Z S, et al.Manufacturing and banking canine adipose-derived mesenchymal stem cells for veterinary clinical application[J].BMC Vet Res, 2021, 17(1):96.
[21]	FROHLICH J, KUBICKOVA S, MUSILOVA P, et al.Karyotype relationships among selected deer species and cattle revealed by bovine FISH probes[J].PLoS One, 2017, 12(11):e0187559.
[22]	DE LORENZI L, PLANAS J, ROSSI E, et al.New cryptic karyotypic differences between cattle (Bos taurus) and goat (Capra hircus)[J].Chromosome Res, 2015, 23(2):225-235.
[23]	DOMINICI M, LE BLANC K, MUELLER I, et al.Minimal criteria for defining multipotent mesenchymal stromal cells.The International Society for Cellular Therapy position statement[J].Cytotherapy, 2006, 8(4):315-317.
[24]	GOMEZ K E, WU F L, KEYSAR S B, et al.Cancer cell CD44 mediates macrophage/monocyte-driven regulation of head and neck cancer stem cells[J].Cancer Res, 2020, 80(19):4185-4198.
[25]	LI Q, HOU H F, LI M, et al.CD73+ mesenchymal stem cells ameliorate myocardial infarction by promoting angiogenesis[J].Front Cell Dev Biol, 2021, 9:637239.
[26]	LU S H, GE M L, ZHENG Y Z, et al.CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia[J].Stem Cell Res Ther, 2017, 8(1):178.
[27]	吴芳春.牛胰腺间充质干细胞的分离培养及其生物学特性的研究[D].北京:中国农业科学院, 2014.WU F C.Research on isolation, culture and biological characteristics of bovine pancreatic mesenchymal stem cells[D].Beijing:Chinese Academy of Agricultural Sciences, 2014.(in Chinese)
[28]	PARK S, ARAI Y, KIM B J, et al.Suppression of SPRY4 promotes osteogenic differentiation and bone formation of mesenchymal stem cell[J].Tissue Eng Part A, 2019, 25(23-24):1646-1657.
[29]	HAN L Z, WANG B, WANG R Y, et al.The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor[J].Stem Cell Res Ther, 2019, 10(1):377.
[30]	YUAN Z Y, LI Q, LUO S H, et al.PPARγ and Wnt signaling in adipogenic and osteogenic differentiation of mesenchymal stem cells[J].Curr Stem Cell Res Ther, 2016, 11(3):216-225.
[31]	LIN L, LI M T, LUO J S, et al.A high proportion of novel ACAN mutations and their prevalence in a large cohort of Chinese short stature children[J].J Clin Endocrinol Metab, 2021, 106(7):e2711-e2719.
[32]	SONG H, PARK K H.Regulation and function of SOX9 during cartilage development and regeneration[J].Semin Cancer Biol, 2020, 67:12-23.
[33]	LI S N, WU J F.TGF-β/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment[J].Stem Cell Res Ther, 2020, 11(1):41.
[34]	梁婷婷, 陈黎, 范明松, 等.体外诱导人胎盘来源间充质干细胞向肝细胞分化[J].中国组织工程研究, 2022, 26(24):3870-3874.LIANG T T, CHEN L, FAN M S, et al.In vitro differentiation of human placenta-derived mesenchymal stem cells into hepatocytes[J].Chinese Journal of Tissue Engineering Research, 2022, 26(24):3870-3874.(in Chinese)